Related Experiment Video
Updated: Feb 18, 2026

11:06
Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth
Published on: April 23, 2019
8.3K
Ketoconazole Therapy in Pityriasis Versicolor.
Indian Journal of Dermatology, Venereology and Leprology
|February 3, 2017
Summary
A 14-day course of oral ketoconazole demonstrated a higher cure rate for pityriasis versicolor compared to a 10-day regimen. This antifungal treatment showed minimal side effects, with only one patient experiencing nausea.
Area of Science:
- Dermatology
- Mycology
- Pharmacology
Background:
- Pityriasis versicolor is a common superficial fungal infection.
- Ketoconazole is an imidazole antifungal agent used to treat fungal infections.
Purpose of the Study:
- To compare the efficacy of 10-day versus 14-day oral ketoconazole courses for treating pityriasis versicolor.
- To assess the safety and recurrence rates associated with these treatment durations.
Main Methods:
- Twenty-six patients diagnosed with pityriasis versicolor were enrolled.
- Treatment involved oral ketoconazole administered for either 10 or 14 consecutive days.
Main Results:
- The 14-day ketoconazole schedule achieved a higher cure rate than the 10-day schedule.
- One patient experienced recurrence of the infection.
- Adverse effects were minimal, with only one case of significant nausea reported.
Conclusions:
- A 14-day course of oral ketoconazole is more effective for pityriasis versicolor than a 10-day course.
- Oral ketoconazole is generally well-tolerated for this indication.
- Longer treatment duration may improve outcomes and reduce recurrence.
Related Concept Videos
Fungal Phylum Microsporidia
582
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
582
Skin Diseases and Disorders
5.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.8K
Skin Cancer
6.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.2K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.7K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.7K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
538
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
538
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
563
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
563

